Equity | 12M Target Price (TRY) | ROI Potential | Portfolio Weight |
ENTRA | 18,60 | 54% | 8% |
KCHOL | 323,00 | 76% | 16% |
MPARK | 535,00 | 53% | 7% |
MGROS | 788,00 | 75% | 12% |
OTKAR | 760,00 | 39% | 10% |
TCELL | 140,00 | 44% | 10% |
TRGYO | 107,00 | 47% | 8% |
TOASO | 455,00 | 72% | 16% |
TUPRS | 238,00 | 22% | 13% |
YKBNK | 34,00 | 27% | 12% |
ROI potential is calculated based on the stock prices as of September 23, 2025.
MAVİ Removed from Recommendation List
As part of our latest update, we have removed Mavi from our recommendation list. Persistent weakness in consumer demand and intensifying competitive pressures have resulted in a real year-on-year revenue contraction of 9% during the first half of 2025. Consequently, management has revised its full-year revenue guidance to reflect a low single-digit decline. While preliminary revenue figures for September suggest a modest recovery driven by the back-to-school season, we anticipate that revenues will remain broadly flat in real terms throughout the second half of the year.
Although we continue to hold a positive long-term view supported by potential improvements in macroeconomic conditions, we believe that the scope for growth in the medium term remains limited.
Following this update, we have also rebalanced the equity weightings within our portfolio. Accordingly, we maintain Tofaş and Koç Holding as our top-weighted positions. Based on our analysts’ assessments, these two stocks offer the highest return potential among the equities under coverage.